
Veronika Bridgman
Co-founder and CEO
Product and data leader who created her own hormone-tracking systems over 15 years ago.
Unravel Health turns a decade of University of Glasgow biosensor research into a lab you can keep at home. London and Glasgow.
Co-founder and CEO Veronika Bridgman lives with PMOS, formerly known as PCOS. Years before Unravel, she built her own hormone tracker because one-off tests could not show what her body was doing day to day. Micro Lab grew out of that need: real hormone readings, taken as often as the question requires.
“Fifteen years ago I built my own hormone tracker to manage PMOS because a blood test told me almost nothing.”
“Reading hormones in saliva outside a lab has been our Everest.”
Product, commercial, clinical and sensor science in one room, with the inventors of the core technology.

Co-founder and CEO
Product and data leader who created her own hormone-tracking systems over 15 years ago.

Co-founder
Commercial leader who scaled a healthtech company from early stage to IPO.

Co-founder
Internal Medicine doctor and biomedical engineer translating hormone data into better care.

Fractional CSO, Hardware
Inventor of Unravel's core sensor technology and a leader in nanoengineering.

Fractional CSO, Biosensor
Biosensor and assay expert, University of Glasgow lecturer and co-inventor of the platform.

Senior Development Scientist
Microfluidics engineer leading the saliva cartridge development.

Research Lead
Leads large-scale studies, ethics and patient involvement with UK academic partners.
Announced in October 2026, the round is led by Conduit EIS Impact Fund and Wrightwood, with Leo Capital, Embryo Ventures, Hermesa and returning investor Zinc.
For interviews, images and the prototype story, write to info@unravel.health.